comparemela.com

Latest Breaking News On - Ac immune sa - Page 5 : comparemela.com

AC Immune to Present at the AD/PD™ 2022 New Clinical and Preclinical Data for Alpha-Synuclein, Abeta and TDP-43 Programs

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Comunidad autonoma de catalunaGary waandersMarija vukicevicSaoyuth nidhAshani lewisTariq afrozEli lillyJohannes strefferAndrea pfeiferCorey davisTamara seredeninaFrancesca capotostiInternational conference on alzheimer parkinson diseasesJanssen pharmaceuticals incUniversity hospitalExchange commission

AC Immune to Present at the SVB Leerink 11th Annual Global

LAUSANNE, Switzerland, Feb. 02, 2022 (GLOBE NEWSWIRE) AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision.

Andrea pfeiferEli lillyRoche groupJanssen pharmaceuticals incAnnual global healthcare conferenceEvents pageJanssen pharmaceuticalsNasdaq aciuAc immune sa

AC Immune Awarded Two Michael J Fox Foundation Grants to Advance Small Molecule Parkinson s Disease Programs

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Yves kremerAndrea pfeiferMarco baptistaSaoyuth nidhAshani lewisCorey davisEli lillyOur foundationJanssen pharmaceuticals incResearch programsExchange commissionTeam foxSecurities exchangeMichaelj fox foundationRoche groupMichaelj fox foundation for parkinson research

AC Immune Holds its Extraordinary General Meeting and

Dr. Shaw is a pharmaceutical industry expert who has been involved in advancing more than 15 therapeutic products from first-in-human studies through.

Nasdaq aciuAc immune sa

AC Immune Provides Update on Alzheimer s Disease Vaccine

Optimized vaccine candidate generates enhanced polyclonal antibody response against pyroglutamate Abeta in non-human primates Phase 2 interim analysis.

Chris maggosAndrea pfeiferKatie gallagherPyroglutamate abetaEli lillyJoshua drummLavoie health scienceCorporate communicationsJanssen pharmaceuticals incRoche groupInvestigational new drugJanssen pharmaceuticalsInvestor relationsNasdaq aciuAc immune saஆண்ட்ரியா பபெபேற்

vimarsana © 2020. All Rights Reserved.